Table 1

Report on drug use in maintenance therapy of symptomatic heart failure related to dilated cardiomyopathy

Initial therapyAdd-on therapyParticipants that gave duplicate answersOverall total
Drug classn/total%n/total%nn/total%
Angiotensin receptor blocker2/10028/100819/1009
Loop diuretic76/1007619/10019392/10092
Thiazide diuretic14/1001421/10021233/10033
Aldosterone antagonist65/1006527/10027488/10088
Cardiac glycoside16/1001639/10039154/10054
  • The results corresponding to two multiple-choice questions are presented, one referring to initial therapy and one referring to add-on therapy prescribed for patients that remain symptomatic despite initial therapy. Some of the participants gave a duplicate answer, as they selected the same drug class in both questions (column ‘Participants that gave a duplicate answer’). The total number of physicians that reported prescribing each drug class for the therapy of DCM-related symptomatic heart failure is presented under column ‘overall total’.

  • Drugs reported under ‘other’ were acetylsalicylic acid and ivabradine for initial therapy and ivabradine and intravenous inotropics for add-on therapy.

  • ACE-I, angiotensin-converting enzyme inhibitors; DCM, dilated cardiomyopathy.